Novavax Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 1.25% to $11.09 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.00% to 11,887.45 and Dow Jones Industrial Average falling 0.10% to 33,891.02. This was the stock's second consecutive day of losses. Novavax Inc. closed $90.30 short of its 52-week high ($101.39), which the company reached on February 7th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.76% to $163.36, Pfizer Inc. (PFE) fell 0.68% to $43.76, and Merck & Co. Inc. (MRK) rose 1.06% to $104.03. Trading volume (4.1 M) remained 3.5 million below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 6, 2023.
(END) Dow Jones Newswires
February 06, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.